Healthcare Third-Party Logistics (3PL) Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)
The global Healthcare Third-Party Logistics (3PL) Market size is forecast to increase from $305.22 Million in 2026 to $590.54 Million in 2034 at a CAGR of 8.6% between 2026 and 2034.
The Healthcare Third-Party Logistics (3PL) market report provides detailed analysis and outlook of Healthcare Third-Party Logistics (3PL) segments including By Service Type (Transportation, Warehousing & Storage, Inventory & Order Management, Value-Added Services ), By Supply Chain Category (Cold Chain Logistics, Non-Cold Chain Logistics ), By Product Type (Pharmaceutical Products, Medical Devices & Consumables, Biological & Blood Products, Surgical & Laboratory Equipment), By End-User (Biopharmaceutical & Pharmaceutical Companies, Medical Device Manufacturers, Hospitals & Large Clinics, Pharmacy Benefit Managers (PBMs) & Retail Pharmacies) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Healthcare Third-Party Logistics (3PL) Industry Overview
Specialized Healthcare Supply Chains Driving Industry Transformation
The healthcare third-party logistics industry is undergoing rapid expansion as pharmaceutical manufacturers, biotechnology companies, clinical research organizations, and healthcare providers increasingly require specialized supply chain solutions for temperature-sensitive and high-value medical products. The growing complexity of biologics, cell and gene therapies, vaccines, and clinical trial materials is driving demand for advanced logistics networks capable of maintaining product integrity throughout transportation and storage. Healthcare 3PL providers are investing heavily in cold chain infrastructure, real-time monitoring systems, predictive analytics, and integrated visibility platforms to support increasingly stringent regulatory and quality requirements across global healthcare supply chains.
Strategic Acquisitions Expanding Cold Chain Capabilities
Industry consolidation is strengthening the ability of major logistics providers to manage specialized healthcare transportation requirements. United Parcel Service expanded its healthcare logistics footprint through the acquisition of Andlauer Healthcare Group, a leading provider of healthcare-focused supply chain solutions in Canada. The transaction integrates Andlauer’s temperature-controlled transportation network, specialized warehousing assets, and healthcare logistics expertise into the UPS Healthcare ecosystem. By incorporating Andlauer’s extensive cold chain infrastructure and cross-border distribution capabilities, UPS is enhancing its capacity to support biologics, vaccines, clinical trial materials, and other highly sensitive healthcare products throughout North America while improving end-to-end supply chain visibility.
Real-Time Monitoring and Predictive Analytics Enhancing Shipment Integrity
Technology-driven logistics management is becoming a defining feature of modern healthcare 3PL operations. FedEx expanded the deployment of its FedEx Surround platform, an advanced monitoring solution designed specifically for sensitive healthcare shipments. The system utilizes SenseAware ID sensor technology to transmit real-time location and environmental condition data at two-second intervals through secure cloud-based platforms. These continuous data streams are analyzed through artificial intelligence-powered control tower dashboards, enabling logistics teams to proactively identify potential transportation disruptions, customs delays, or temperature excursion risks. Such predictive capabilities support the secure delivery of specialized pharmaceuticals, medical devices, cell therapies, and weight management treatments while reducing supply chain vulnerabilities.
Pharmaceutical Infrastructure Investments Supporting Regional Distribution
Healthcare logistics providers continue to expand their specialized storage and distribution infrastructure to meet growing pharmaceutical demand. DHL Supply Chain strengthened its Life Sciences and Healthcare network through the opening of a dedicated pharmaceutical logistics hub in Singapore. The facility incorporates Good Manufacturing Practice-compliant infrastructure with controlled ambient and refrigerated storage environments designed to support pharmaceutical distribution throughout the region. Specialized loading systems help maintain uninterrupted temperature control during handling and transportation activities. These investments reflect the broader industry trend toward developing highly specialized logistics facilities capable of supporting increasingly sophisticated healthcare supply chains while maintaining product quality, regulatory compliance, and operational efficiency.
Healthcare Third-Party Logistics (3PL) Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Healthcare Third-Party Logistics (3PL) market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- DHL Supply Chain, Kuehne + Nagel International AG, UPS Healthcare, FedEx Logistics, DB Schenker, CEVA Logistics, DSV Panalpina A/S, XPO Logistics, GEODIS, Marken (a UPS Company). The Healthcare Third-Party Logistics (3PL) market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Healthcare Third-Party Logistics (3PL) industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
-
Growth Healthcare Third-Party Logistics (3PL) Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
-
Market Trends, Drivers, Potential Opportunities, and Challenges faced by Healthcare Third-Party Logistics (3PL) companies
-
Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
-
Detailed SWOT Analysis of global and regional Healthcare Third-Party Logistics (3PL) markets
-
Competitive analysis including business description, product analysis, and financial profiles
-
Key country specific analysis detailing key factors shaping the short-term and long-term outlook
-
Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Healthcare Third-Party Logistics (3PL) Market Competitive Benchmarking and Company Analysis
Leading companies in Healthcare Third-Party Logistics (3PL) industry include- DHL Supply Chain, Kuehne + Nagel International AG, UPS Healthcare, FedEx Logistics, DB Schenker, CEVA Logistics, DSV Panalpina A/S, XPO Logistics, GEODIS, Marken (a UPS Company). The Healthcare Third-Party Logistics (3PL) market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Healthcare Third-Party Logistics (3PL) Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Healthcare Third-Party Logistics (3PL) market remains one of the strongest-performing segments in the country.
The US Healthcare Third-Party Logistics (3PL) Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Healthcare Third-Party Logistics (3PL) market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Healthcare Third-Party Logistics (3PL) industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Healthcare Third-Party Logistics (3PL) markets
Canada's strong Healthcare Third-Party Logistics (3PL) sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Healthcare Third-Party Logistics (3PL) market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Healthcare Third-Party Logistics (3PL) Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Healthcare Third-Party Logistics (3PL) market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Healthcare Third-Party Logistics (3PL) population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Healthcare Third-Party Logistics (3PL) industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Healthcare Third-Party Logistics (3PL) market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Healthcare Third-Party Logistics (3PL) sales through 2034
France Healthcare Third-Party Logistics (3PL) companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Healthcare Third-Party Logistics (3PL) Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Healthcare Third-Party Logistics (3PL) distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Healthcare Third-Party Logistics (3PL) Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Healthcare Third-Party Logistics (3PL) market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Healthcare Third-Party Logistics (3PL) industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Healthcare Third-Party Logistics (3PL) industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Healthcare Third-Party Logistics (3PL) Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Healthcare Third-Party Logistics (3PL) market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Healthcare Third-Party Logistics (3PL) market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Healthcare Third-Party Logistics (3PL) Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Healthcare Third-Party Logistics (3PL) Market Segmentation
By Service Type
Transportation
Warehousing & Storage
Inventory & Order Management
Value-Added Services
By Supply Chain Category
Cold Chain Logistics
Non-Cold Chain Logistics
By Product Type
Pharmaceutical Products
Medical Devices & Consumables
Biological & Blood Products
Surgical & Laboratory Equipment
By End-User
Biopharmaceutical & Pharmaceutical Companies
Medical Device Manufacturers
Hospitals & Large Clinics
Pharmacy Benefit Managers (PBMs) & Retail Pharmacies
Top Companies in Healthcare Third-Party Logistics (3PL) Industry
DHL Supply Chain
Kuehne + Nagel International AG
UPS Healthcare
FedEx Logistics
DB Schenker
CEVA Logistics
DSV Panalpina A/S
XPO Logistics
GEODIS
Marken (a UPS Company)
Countries Included
-
North America- US, Canada, Mexico
-
Europe- Germany, France, UK, Spain, Italy, Nordics, Others
-
Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
-
Latin America- Brazil, Argentina, Others
-
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Latest Market Updates In Healthcare
Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.
Low MOQ, High-Mix Production Models for Indie & DTC Brands
The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...
Market UpdateRise of Functional and Clinical-Grade Skincare
The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...
Market UpdateBiotech and Fermented Ingredient Integration to gain rapid penetration
The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...
By Service Type
Transportation
Warehousing & Storage
Inventory & Order Management
Value-Added Services
By Supply Chain Category
Cold Chain Logistics
Non-Cold Chain Logistics
By Product Type
Pharmaceutical Products
Medical Devices & Consumables
Biological & Blood Products
Surgical & Laboratory Equipment
By End-User
Biopharmaceutical & Pharmaceutical Companies
Medical Device Manufacturers
Hospitals & Large Clinics
Pharmacy Benefit Managers (PBMs) & Retail Pharmacies